about
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral thThe efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials.HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacologic therapy for HIV-associated lipodystrophy.
@ast
Pharmacologic therapy for HIV-associated lipodystrophy.
@en
type
label
Pharmacologic therapy for HIV-associated lipodystrophy.
@ast
Pharmacologic therapy for HIV-associated lipodystrophy.
@en
prefLabel
Pharmacologic therapy for HIV-associated lipodystrophy.
@ast
Pharmacologic therapy for HIV-associated lipodystrophy.
@en
P2860
P356
P1476
Pharmacologic therapy for HIV-associated lipodystrophy.
@en
P2093
Milap C Nahata
Sandra Benavides
P2860
P304
P356
10.1345/APH.1D081
P407
P577
2004-01-30T00:00:00Z